
Sofinnova Partners Raises EUR472m for Europe’s largest early-stage healthcare VC fund
Sofinnova Partners, a European life sciences venture capital firm based in Paris, London and Milan, has closed its latest early-stage healthcare venture capital fund, Sofinnova Capital X, oversubscribed at EUR472 million (USD548 million).
